CRISPR-Cas9 identifies growth-related subtypes of glioblastoma with therapeutical significance through cell line knockdown. Zhao N, Weng S, Liu Z, Xu H, et al. BMC Cancer 2023;23:749.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhao N, Weng S, Liu Z, Xu H, et al. CRISPR-Cas9 identifies growth-related subtypes of glioblastoma with therapeutical significance through cell line knockdown. BMC Cancer 2023;23:749.
PMID: 37580710